Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proteins and peptides are biological polymers composed of amino acid residues joined by peptide bonds, varying primarily in length and folding complexity (NIH, 2023). They are essential to all biological processes, acting as enzymes, structural components, and signaling molecules within every living organism (UniProt, 2024). However, the term Proteins and peptides is a broad chemical classification rather than a specific, actionable therapeutic target like a single receptor or enzyme. In the context of drug development, this category is too heterogeneous to define a specific mechanism of action or disease role, as it encompasses the majority of the proteome. Therefore, while they are the basis for most drug targets and many therapeutic agents, the term itself is considered an incorrect or overly broad designation for a target (PubChem, 2024).
Not applicable as this is a broad molecular class rather than a specific target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteins and peptides.